쿼드메디슨

464490· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩5,850+2.27%

2026-08-04

Financials

Valuation Metrics

쿼드메디슨's Market Cap is ₩672B. At end of 2025 it was ₩1790B. Ranked #1528 of 2,436 in KR market (top 63%), #886 of 1,649 on KOSDAQ (top 54%), #171 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 73%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	67.17B KRW	KR#1,528/2,436 Sec#171/234
Revenue	9.78B KRW	KR#2,293/2,436 Sec#179/234
Net Income	-8.13B KRW	KR—/2,436 Sec—/234
Total Assets	46.59B KRW	KR#2,213/2,436 Sec#202/234
Net Assets	26.89B KRW	KR#2,193/2,436 Sec#199/234
Value
P/B	2.50x	KR#2,031/2,436 Sec#156/234
P/S	6.87x	KR#2,208/2,436 Sec#148/234
FCF Yield	-10.03%	KR—/2,436 Sec—/234
Profitability
ROE	-30.23%	KR#2,168/2,436 Sec#172/234
ROA	-17.45%	KR#2,208/2,436 Sec#172/234
Op. Margin	-76.14%	KR#2,286/2,436 Sec#168/234
Revenue Growth	-76.97%	KR#2,333/2,436 Sec#209/234
Financial Health
Debt Ratio	173.26%	KR#1,472/2,436 Sec#169/234
Total Debt	6.93B KRW	KR#1,728/2,436 Sec#161/234
FCF	-6.74B KRW	KR#1,584/2,436 Sec#127/234
Cash	11.95B KRW	KR#1,567/2,436 Sec#119/234
Current Ratio	2.58x	KR#721/2,436 Sec#90/234
Performance
1M Return	-2.34%	KR#1,143/2,436 Sec#110/234
From 52W High	-78.45%	KR#2,333/2,436 Sec#217/234
1Y MDD	-79.67%	KR#2,290/2,436 Sec#212/234
Trading
Volume	23,591 shares	KR#1,776/2,436 Sec#179/234
Foreign Own.	1.74%	KR—/2,436 Sec—/234
Per Share
EPS	-801 KRW	KR—/2,436 Sec—/234
BPS	2,342 KRW	KR#1,950/2,436 Sec#159/234